Skip to main content
Top

Drugs

Issue 3/2012

Content (10 Articles)

Optimum Bronchodilator Combinations in Chronic Obstructive Pulmonary Disease

  • Current Opinion

Matthew C. Miles, James F. Donohue, Jill. A. Ohar

Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents

  • Therapy In Practice

Ann C. Childress, Sally A. Berry

Pharmacokinetics of Intravenous Ibuprofen

  • Review Article

Howard S. Smith, Bryan Voss

Antibacterials as Adjuncts to Incision and Drainage for Adults with Purulent Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infections

  • Review Article

Nicolas A. Forcade, Nathan P. Wiederhold, Laurajo Ryan, Robert L. Talbert, Christopher R. Frei

Pertuzumab

  • Adis Drug Profile

Gillian M. Keating

Azithromycin 1.5% Ophthalmic Solution

  • Adis Drug Profile

Karly P. Garnock-Jones

Tapentadol Extended Release

  • Adis Drug Profile

Sheridan M. Hoy

Budesonide/Formoterol Turbuhaler®

  • Adis Drug Evaluation

Lesley J. Scott

Romiplostim

  • Adis Drug Evaluation

Gillian M. Keating

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images